Moreover, we have defined a novel mechanism by which ErbB signaling suppresses basal IFN signaling that may promote the survival and proliferation of HMLECs and that may have implications for breast cancer metastasis and treatment. This evidence concerns the gene IFNA1 and breast cancer.